ArticleFrontiers in cellular and infection microbiology2025
Decoding respiratory syncytial virus morphology: distinct structural and molecular signatures of spherical and filamentous particles.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- RSV vaccine development: advances and fusion protein-focused strategies.Frontiers in immunology · 2026Review
- Advances in molecular regulation and function of LDLR family in viral infection.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory syncytial virus (RSV) is a pleomorphic enveloped virus that buds as both spherical and filamentous particles. The determinants of RSV particle morphology and the roles of these forms in transmission and pathogenicity are not clearly defined, owing to a complex interplay of viral proteins and host factors that remains poorly understood. To further characterize RSV morphology, we developed a sucrose gradient velocity sedimentation method to separate spherical and filamentous virions. Fluorescence microscopy and electron microscopy (EM) confirmed two distinct peaks containing predominantly spherical or filamentous particles, respectively. Notably, EM images revealed a distinctive "honeycomb" pattern on the RSV envelope, suggesting an ordered lattice of glycoproteins on the virion surface. Biochemical analyses of viral protein and lipid content showed that filamentous particles contained higher levels of uncleaved fusion protein F0 and exhibited distinct phospholipid profiles compared to spherical particles. Both forms were enriched in cholesterol and phospholipids characteristic of lipid rafts, consistent with the idea that RSV buds from lipid raft microdomains. This enrichment in raft lipids is linked to cell-to-cell fusion (syncytium) formation and virion assembly. Quantitative real-time PCR analysis indicated a high particle-to-PFU ratio (~4:1), meaning only about one in four RSV virions was infectious. Spherical particles contained on average ~3 genomic RNA copies per virion, whereas filamentous particles contained ~2 copies. These data reveal several structural and compositional differences between RSV particle morphologies that may influence viral pathogenesis, and they provide a foundation for new antiviral approaches targeting virion assembly and morphology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.